Dova Pharmaceuticals: 3Q Earnings Snapshot
DURHAM, N.C. (AP) _ Dova Pharmaceuticals Inc. (DOVA) on Thursday reported a loss of $19.5 million in its third quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 69 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.
The pharmaceutical company posted revenue of $2.9 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $2.7 million.
Dova Pharmaceuticals shares have fallen 33 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.30, a drop of 20 percent in the last 12 months.